Navigation Links
A new mechanism inhibiting the spread and growth of cancer found in motile cells
Date:10/21/2011

A revolutionary discovery regarding motile cancer cells made by research scientists at VTT Technical Research Centre of Finland and the University of Turku is challenging previous conceptions. The results have been published on July 25, 2011 in the Journal of Cell Biology, one of the most renowned journals in the field.

Finnish researchers found a new mechanism inhibiting the spread and growth of cancer found in motile cells

It has long been held that cells use different mechanisms for regulating migration and growth. This conception was proven false by research scientists Anja Mai and Stefan Veltel from the research team of Professor Johanna Ivaska. Their findings on aggressively spreading breast cancer cells revealed completely contrary to previous expectations that a single cell protein (p120RasGAP) acts as an important inhibitor of both cell migration and growth.

Cancer cells are characterised by traits such as uncontrollable growth and the ability to metastasise. The findings of the research team now show that the regulation of these two deadly traits in cells is interconnected, which may be an important piece of information in the future development of medicines.


'/>"/>

Contact: Johanna Ivaska
Johanna.Ivaska@vtt.fi
358-207-222-807
VTT Technical Research Centre of Finland
Source:Eurekalert

Page: 1

Related medicine news :

1. Discovery of a cell mechanism that reduces effectiveness of breast cancer treatment
2. Researchers investigate new mechanism for predicting how diseases spread
3. Scientists receive funding boost to further research into disease mechanisms of Alzheimer’s
4. Fox Chase researchers identify new mechanism used by cells to reverse silenced genes
5. Scientists identify a novel mechanism for evolution of highly aggressive cancers
6. Discovery of a new mechanism of gene control that is associated with cancer
7. UofL researchers uncover mechanism in saliva production
8. Mechanism discovered for health benefit of green tea, new approach to autoimmune disease
9. Intestinal cell defense mechanism against bacteria
10. Mechanism behind compounds effects on skin inflammation and cancer progression
11. The peculiar feeding mechanism of the first vertebrates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... VA (PRWEB) , ... June 23, 2017 , ... ... of what is needed and will ultimately do significant harm to people with ... to everyone. , "While it leaves in place the Affordable Care Act ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids and ... of visual loss in these patients. , But how often do ophthalmologists and optometrists ... to patients at risk of or with early symptoms of AMD? A study ...
(Date:6/23/2017)... ... 2017 , ... Military Connection friend and veteran advocate Micaela Bensko ... Atlantic lounge. , Bensko is no stranger to the plight of the disabled. ... life to supporting our wounded veterans. A world-class photographer, her riveting photos “The Wounds ...
(Date:6/23/2017)... ... 2017 , ... The Aesthetic Channel has recently highlighted Dr. Ben Talei’s unique ... a proprietary technique that he calls the AuraLyft Facelift. The AuraLyft does ... patients can expect to look refreshed, rejuvenated, and revitalized. , Dr. Talei’s unique ...
(Date:6/23/2017)... ... June 23, 2017 , ... 21 Middle East and South Asia ... 21 leaders from government, business and civil society in 11 countries across the Middle ... fall, engaging in a transformative exchange of knowledge and ideas with the leading minds ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 2017  StatLab Medical Products ("StatLab" or ... of diagnostic supplies for the anatomic pathology ... Company LP ("Cressey & Company"), a healthcare-focused ... investment in the Company. Cressey & Company ... selling shareholder, Prairie Capital, L.P., with certain ...
(Date:6/7/2017)... 2017  Diplomat Specialty Infusion Group, a brand of Diplomat Pharmacy, ... Iowa location. The ... features an ISO 7 cleanroom—the standard needed to compound intravenous (IV) ... level of pollutants. "Our new ... better serve our Iowa patients," said ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: